Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Targets & Mechanisms

Los Alamos team opens door to allosteric COVID-19 countermeasures

BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.

Sandi Wong, Assistant Editor
May 6, 2020 11:41 PM UTC
Updated on May 8, 2020 at 10:48 PM UTC

A SARS-CoV-2 spike mutation linked to locally dominant strains could become the basis for allosteric COVID-19 countermeasure development.

A Los Alamos National Laboratory team has identified a SARS-CoV-2 spike mutation linked to locally dominant strains that could become the basis of allosteric COVID-19 countermeasure development...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Los Alamos National Laboratory